Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer

Experimental and Molecular Pathology

Volumn 77, Issue 2, 2004, Pages 153-159

  Sinha, Akhouri A ^a,b   Quast, Barry J ^a   Reddy, Pranav K ^b   Lall, Vikas ^c   Wilson, Michael J ^a,b,c   Qian, Jungi ^d   Bostwick, Davidg ^d,e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d BOSTWICK LABORATORIES   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Basal cells; Basement membrane; Cytokeratin 34BE 12; Heparan sulphate proteoglycan; High grade prostatic intraepithelial neoplasia (HGPIN); Microvessel density; Prostate cancer; von Willebrand factor VIII

Indexed keywords

ANTIBODY; CYTOKERATIN; IMMUNOGLOBULIN G; PROTEOHEPARAN SULFATE; TUMOR MARKER; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; CYSTECTOMY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; PROSTATE CANCER; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RANDOMIZATION; TISSUE SECTION;

AGED; DISEASE PROGRESSION; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; VON WILLEBRAND FACTOR;

ORYCTOLAGUS CUNICULUS;

EID: 4444242896     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexmp.2004.04.005     Document Type: Article

References (38)

1. Abrahams N.A., Bostwick D.G., Ormsby A.H., Qian J., Brainard J.A. Distinguishing atrophy and high-grade prostatic intraepithelial neoplasia from prostatic adenocarcinoma with and without previous adjuvant hormone therapy with the aid of cytokeratin 5/6. Am. J. Clin. Pathol. 120:2003;368-376
2. Bostwick D.G. High grade prostatic intraepithelial neoplasia. The most likely precursor of prostate cancer. Cancer. 75:1995;1823-1836
3. Bostwick D.G., Brawer M.K. Prostatic intra-epithelial neoplasia and early invasion in prostatic cancer. Cancer. 59:1987;788-794
4. Bostwick D.G., Amin M.B., Dundore P., Marsh W., Schultz D.S. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum. Pathol. 24:1993;298-310
5. Bostwick D.G., Leske D.A., Qian J., Sinha A.A. Prostatic intraepithelial neoplasia and well differentiated adenocarcinoma maintain an intact basement membrane. Pathol., Res. Pract. 191:1995;850-855
6. Bostwick D.G., Pacelli A., Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate. 29:1996;117-134
7. Brawer M.K., Deering R.E., Brawn M., Preston S.D., Bigler S.A. Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer. 73:1994;678-687
8. Chan T.Y., Mikolajczyk S.D., Lecksell K., Shue M.J., Rittenhouse H.G., Partin A.W., Epstein J.I. Immunohistochemical staining of prostate cancer with monoclonal antibodies to the precursor of prostate-specific antigen. Urology. 62:2003;177-181
9. Coogan C.L., Bostwick D.G., Bloom K.J., Gould V.E. Glycoprotein A-80 in the human prostate:immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy. Urology. 61:2003;248-252
10. Davidson D., Bostwick D.G., Qian J., Wollan P.C., Oesterling J.E., Rudders R.A., Siroky M., Stilmant M. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J. Urol. 154:1995;1295-1299
11. Ellis W.J., Lange P.H. Prostate cancer. Endocrinol. Metab. Clin. North Am. 23:1994;809-824
12. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934
13. Gleason D.F., V.A.C.U.R.G. (Veterans Administration Cooperative Urological Research Group) Histologic grading and clinical staging of prostatic carcinoma. Tannenbaum M. In Urologic Pathology: The Prostate. 1977;171-213 Lea & Febiger, Philadelphia
14. Haggman M.J., Macoska J.A., Wojna K.A., Oesterling J.E. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J. Urol. 158:1997;12-22
15. Kronz J.D., Allan C.H., Shaikh A.A., Epstein J.I. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasis on needle biopsy. Am. J. Surg. Pathol. 25:2001;1079-1085
16. Kronz J.D., Shaikh A.A., Epstein J. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Hum. Pathol. 32:2001;389-395
17. Kronz J.D., Milord R., Wilentz R., Weir E.G., Schreiner S.R., Epstein J.I. Lesions missed on prostate biopsies in cases sent in for consultation. Prostate. 54:2003;310-314
18. Leav I., McNeal J.E., Kwan P.W.L., Komminoth P., Merk F.B. Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate. An immunohistochemical and in situ hybridization study. Prostate. 29:1996;137-145
19. Lefkowitz G.K., Sidhu G.S., Torre P., Lepor H., Taneja S. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after 12-core sampling? Urology. 58:2001;999-1003
20. Lefkowitz G.K., Taneja S.S., Brown J., Melamed J., Lepor H. Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels. J. Urol. 168:2002;1415-1418
21. McNeal J.E., Bostwick D.G. Intraductal dysplasia: a premalignant lesion of the prostate. Hum. Pathol. 17:1986;64-71
22. Meng M.V., Shinohara K., Grossfeld G.D. Significance of high-grade prostatic intraepithelial neoplasia on prostate biopsy. Urol. Oncol. 21:2003;145-151
23. Munoz E., Gomez F., Paz J.I., Silva J.M., Corcuera M.T., Alonso M.J. Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation. Eur. J. Histochem. 47:2003;123-128
24. Naya Y., Ayala A.G., Tamboli P., Babaian R.J. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Urology. 63:2004;503-508
25. O'Dowd G.J., Miller M.C., Orozco R., Veltri R.W. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology. 55:2000;553-559
26. Oliai B.R., Kahane H., Epstein J.I. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34 beta E-12) antibody. Am. J. Surg. Pathol. 26:2002;1151-1160
27. Qian J., Bostwick D.G., Takahashi S., Borell T.J., Herath J.F., Lieber M.M., Jenkins R.B. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res. 55:1995;5408-5414
28. Sakr W.A., Partin A.W. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia. Urology. 57(Suppl. 4A):2001;115-120
29. Sakr W.A., Billis A., Ekman P., Wilt T., Bostwick D.G. Epidemiology of high-grade prostatic intraepithelial neoplasia. Scand. J. Urol. Nephrol., Suppl. 205:2000;11-18
30. Sinha A.A., DeLeon O., Reddy P.K., Wilson M.J., Limas C., Gleason D.F., Furcht T. Localization of type IV collagen in the basement membranes of human prostate and lymph nodes by immunoperoxidase and immunoalkaline phosphatase. Prostate. 18:1991;93-104
31. Sinha A.A., Gleason D.F., Staley N.A., Wilson M.J., Sameni M., Sloane B.F. Cathepsin B in angiogenesis of human prostate: an immunohistochemical and immunoelectron microscopic analysis. Anat. Rec. 241:1995;353-362
32. Sinha A.A., Wilson M.J., Gleason D.F., Reddy P.K., Sameni M., Sloane B.F. Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate. 26:1995;171-178
33. Sinha A.A., Quast B.J., Wilson M.J., Reddy P.K., Gleason D.F., Sloane B.F. Co-distribution of pro and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy. Anat. Rec. 252:1998;281-289
34. Sinha A.A., Quast B.J., Korkowski J.C., Wilson M.J., Reddy P.K., Ewing S.L., Sloane B.F., Gleason D.F. The relationship of cathepsin B and stefin A mRNA localization identifies a potentially aggressive variant of human prostate cancer within a Gleason histologic score. Anticancer Res. 19:1999;2821-2830
35. Steiner M.S. High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction. World J. Urol. 21:2003;15-20
36. Vukanovic J., Passaniti A., Hirata T., Traystman R.J., Hartley-Asp B., Issacs J.T. Antiangiogenic effects of the quinoline-3-carboxamide linomide. Cancer Res. 53:1993;1833-1837
37. Wilcox G., Soh S., Chakraborty S., Scardino P.T., Wheeler T.M. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum. Pathol. 29:1998;1119-1123
38. Yamanaka M., Watanabe M., Yamada Y., Takagi A., Murata T., Takahashi H., Suzuki H., Ito H., Tsukino H., Katoh T., Sugimura Y., Shiraishi T. Altered methylation of multiple genes in carcinogenesis of the prostate. Int. J. Cancer. 106:2003;382-387